Leuprolide
Drug timelines are a Plus or Pro feature.
31 regulatory and trial events tracked for Leuprolide, covering 2007-09-20 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss [Phase 2]